NO810351L - G imidazolinderivater og fremgangsmaate til deres fremstillin - Google Patents

G imidazolinderivater og fremgangsmaate til deres fremstillin

Info

Publication number
NO810351L
NO810351L NO810351A NO810351A NO810351L NO 810351 L NO810351 L NO 810351L NO 810351 A NO810351 A NO 810351A NO 810351 A NO810351 A NO 810351A NO 810351 L NO810351 L NO 810351L
Authority
NO
Norway
Prior art keywords
procedures
preparation
imidazoline derivatives
imidazoline
derivatives
Prior art date
Application number
NO810351A
Other languages
English (en)
Other versions
NO154882C (no
NO154882B (no
Inventor
Christopher Bourne Chapleo
Peter Leslie Myers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NO810351L publication Critical patent/NO810351L/no
Publication of NO154882B publication Critical patent/NO154882B/no
Publication of NO154882C publication Critical patent/NO154882C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO810351A 1980-02-04 1981-02-02 Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin. NO154882C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04

Publications (3)

Publication Number Publication Date
NO810351L true NO810351L (no) 1981-08-05
NO154882B NO154882B (no) 1986-09-29
NO154882C NO154882C (no) 1987-01-07

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810351A NO154882C (no) 1980-02-04 1981-02-02 Fremgangsmaate for fremstilling av 2-(2-(1,4-benzodioksanyl)) -2-imidazolin.

Country Status (26)

Country Link
US (1) US4818764A (no)
EP (1) EP0033655B1 (no)
JP (1) JPS56122378A (no)
AR (1) AR225794A1 (no)
AT (1) ATE7228T1 (no)
AU (1) AU535320B2 (no)
CA (1) CA1156241A (no)
CS (1) CS254956B2 (no)
DD (1) DD155991A5 (no)
DE (1) DE3163256D1 (no)
DK (1) DK160092C (no)
ES (1) ES8202553A1 (no)
FI (1) FI67543C (no)
GB (1) GB2068376B (no)
GR (1) GR73853B (no)
HU (1) HU187295B (no)
IE (1) IE51736B1 (no)
IL (1) IL62039A (no)
NO (1) NO154882C (no)
NZ (1) NZ196162A (no)
PH (1) PH16249A (no)
PL (1) PL128368B1 (no)
PT (1) PT72435B (no)
SU (1) SU1128837A3 (no)
ZA (1) ZA81666B (no)
ZW (1) ZW2381A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
EP0115142B1 (en) * 1982-12-23 1986-11-05 Ici Americas Inc. Chroman compounds
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
WO2001064223A1 (en) * 2000-02-29 2001-09-07 Merck Frosst Canada & Co. Method for treating or preventing depression
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
AU2023221400A1 (en) * 2022-02-16 2024-08-29 Terran Biosciences Inc. Deuterated idazoxan and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
CA1156241A (en) 1983-11-01
FI67543C (fi) 1985-04-10
NZ196162A (en) 1983-06-17
EP0033655A2 (en) 1981-08-12
FI810288L (fi) 1981-08-05
IL62039A (en) 1985-01-31
IE810199L (en) 1981-08-04
HU187295B (en) 1985-12-28
JPH0231077B2 (no) 1990-07-11
GB2068376A (en) 1981-08-12
EP0033655A3 (en) 1981-11-25
US4818764A (en) 1989-04-04
IE51736B1 (en) 1987-03-18
CS73881A2 (en) 1987-07-16
ATE7228T1 (de) 1984-05-15
PH16249A (en) 1983-08-16
NO154882C (no) 1987-01-07
ES499034A0 (es) 1982-02-01
ES8202553A1 (es) 1982-02-01
AU535320B2 (en) 1984-03-15
GR73853B (no) 1984-05-07
EP0033655B1 (en) 1984-04-25
DK160092C (da) 1991-06-24
DD155991A5 (de) 1982-07-21
PT72435A (en) 1981-03-01
JPS56122378A (en) 1981-09-25
SU1128837A3 (ru) 1984-12-07
PL229488A1 (no) 1981-10-16
AR225794A1 (es) 1982-04-30
AU6675881A (en) 1981-08-13
IL62039A0 (en) 1981-03-31
FI67543B (fi) 1984-12-31
DK160092B (da) 1991-01-28
ZA81666B (en) 1982-04-28
PL128368B1 (en) 1984-01-31
DK45081A (da) 1981-08-05
DE3163256D1 (en) 1984-05-30
ZW2381A1 (en) 1981-06-24
GB2068376B (en) 1983-06-22
CS254956B2 (en) 1988-02-15
PT72435B (pt) 1982-01-29
NO154882B (no) 1986-09-29

Similar Documents

Publication Publication Date Title
NO821562L (no) Cefalosporinderivater og fremgangsmaate til deres fremstilling
DK224781A (da) Imidazo-rifamycin-derivater og fremgangsmaade til fremstilling deraf
NO813142L (no) N-arylbenzamid-derivater og fremgangsmaate for deres fremstilling.
DK493583A (da) Azolderivater og fremgangsmaade til fremstilling deraf
NO813804L (no) Substituerte pyrimidiner og fremgangsmaate for deres fremstilling
DK468185A (da) Alkylsulfonamidophenylalkylaminer og fremgangsmaade til fremstillingderaf
NO814112L (no) 1-sulfo-2-oksoazetidinderivater og fremgangsmaate for deres fremstilling
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
NO810351L (no) G imidazolinderivater og fremgangsmaate til deres fremstillin
DK446982A (da) Cyanosteroider og fremgangsmaade til deres fremstilling
DK479984A (da) Cephalosporinderivater og fremgangsmaade til deres fremstilling
DK330582A (da) Herbicidt virksomme 5-amino-1-phenylpyrazol-4-carboxylsyrederivater og fremgangsmaade til fremstilling deraf
DK157683A (da) N-phosphonomethylglycinderivater og fremgangsmaade til fremstilling og anvendelse deraf
DK572583A (da) Pyridinderivater og fremgangsmaade til fremstilling deraf
DK108581A (da) 2-penem-3-carboxylsyre-derivater og fremgangsmaade til fremstiling heraf
DK401882A (da) Cyclopentadienderivater og fremgangsmaader til deres fremstilling
NO820258L (no) Imidazolinderivater og fremgangsmaate for deres fremstilling
DK251281A (da) N6-adenosiner og fremgangsmaader til deres fremstilling
NO821206L (no) Imidazolderivater og fremgangsmaate for deres fremstilling
DK401385D0 (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
NO824312L (no) 4-cyano-2-azetidinoner og fremgangsmaate for deres fremstilling
DK118879A (da) 2-hydroxymethyl-pyrazin-derivater og fremgangsmaade til deres fremstilling
DK433381A (da) Fremgangsmaade til fremstilling af 3-brom-4-fluorbenzylalkohol3-brom-4-fluorbenozesyre-derivater og fremgangsmaade til deres fremstilling
DK220982A (da) 7-oxoprostacyklinderivater og fremgangsmaade til fremstilling deraf